Welcome to our dedicated page for Huron Consulting Group news (Ticker: $HURN), a resource for investors and traders seeking the latest updates and insights on Huron Consulting Group stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Huron Consulting Group's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Huron Consulting Group's position in the market.
Huron announced its First Quarter 2024 Financial Results, showing significant growth in total revenues, net income, and adjusted EBITDA. The company returned $62.3 million to shareholders through stock repurchases. Huron closed its acquisition of GG+A, enhancing its philanthropic program capabilities. The company affirms its 2024 revenue and adjusted EBITDA expectations and increases its adjusted diluted earnings per share guidance. Huron's CEO highlighted the growth in Healthcare and Education segments, emphasizing innovation and quality delivery to clients.
